Back to comparisons

Comparison

Rhodiola Rosea vs Chaga

FieldRhodiola RoseaChaga
Categoryadaptogenadaptogen
Dose range200–400mg1000–3000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs460280

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and Chaga are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Chaga Birch-tree mushroom (Inonotus obliquus) traditionally used in Russia/Siberia for immune and antioxidant support.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than Chaga (evidence B, safety 4/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose Chaga if

Chaga is the better fit when your goal aligns with its mechanism (Polysaccharides (beta-glucans), betulinic acid (from the birch tree the fungus grows on), and melanin compounds contribute to antioxidant and immunomodulatory effects) and the dose range (1000–3000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →